A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

This study has been completed.

Study NCT00057525 Information provided by DynPort Vaccine Company LLC, A CSC Company

First Received: April 3, 2003 Last Updated: January 25, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	April 2004
Estimated Primary Completion Date:	No date given